BDBM652738 7-(methyl(2-((1-methylpiperidin-4-yl)methoxy)pyridin-4-yl)amino)quinoxalin-2(1H)-one::US20240059691, Example 4456

SMILES CN1CCC(COc2cc(N(C)c3ccc4ncc(=O)[nH]c4c3)ccn2)CC1

InChI Key InChIKey=KXQJLZZKIBAROO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 652738   

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652738BDBM652738(US20240059691, Example 4456 | 7-(methyl(2-((1-meth...)
Affinity DataIC50: 2.50E+4nMAssay Description:In vitro inhibition of related proteases was determined using an (C50 assay based on standard literature methods (see e.g. Shori et al., Biochem. Pha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652738BDBM652738(US20240059691, Example 4456 | 7-(methyl(2-((1-meth...)
Affinity DataIC50: 7.50E+4nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent